Breyer Capital Partners Morgan Cheatham and Jim Breyer.
Breyer Capital, led by billionaire Jim Breyer, named Morgan Cheatham as Partner and Head of Healthcare and Life Sciences, marking a significant step forward in the firm’s…
Category: 5. Health
-
Breakthrough approach for diagnosing TB could significantly improve detection
A new strategy for tuberculosis (TB) screening, proposed by a team of researchers led by Queen Mary University of London, provides a solution to problems with current TB screening, which does not always accurately detect disease. Simultaneously…
Continue Reading
-
Vision loss fear may keep some from having cataract surgery
Fear of vision loss may deter some patients from undergoing necessary cataract surgery, according to a newly published study. Cataracts are the leading cause of reversible blindness, and surgery remains the only effective treatment.
The study,…
Continue Reading
-
Clinical trials to test vaccine against Alzheimer’s-promoting tau protein
University of New Mexico Health Sciences researchers hope to launch human clinical trials in their quest for a vaccine to prevent the buildup of pathological tau — a protein in the brain associated with Alzheimer’s dementia.
In a new paper…
Continue Reading
-
B cells found to be crucial for long-term vaccine protection, new study shows
Researchers at the University of Colorado Anschutz Medical Campus have uncovered a critical, previously underappreciated role for B cells in vaccine protection. Best known for producing antibodies, B cells also guide other immune cells,…
Continue Reading
-
ATP prevents harmful aggregation of proteins associated with Parkinson’s and ALS
Neurodegenerative disease like Alzheimer’s, Parkinson’s, and ALS (amyotrophic lateral sclerosis) are debilitating conditions that affect millions of people worldwide every year. These pathologies are notoriously difficult to prevent or…
Continue Reading
-
The antibiotic that takes the bite out of Lyme
Lyme disease, a disease transmitted when deer ticks feed on infected animals like deer and rodents, and then bite humans, impacts nearly half a million individuals in the U.S. annually. Even in acute cases, Lyme can be devastating; but early…
Continue Reading
-
Post-treatment Lyme disease syndrome may be driven by remnants of infection
Symptoms that persist long after Lyme disease is treated are not uncommon — a 2022 study found that 14% of patients who were diagnosed and treated early with antibiotic therapy would still develop Post Treatment Lyme Disease (PTLD). Yet doctors…
Continue Reading
-
Researchers identify pathway responsible for calciphylaxis, a rare and serious condition
The global burden of chronic kidney disease (CKD) is rising, with more than 800 million people affected worldwide. Vascular diseases in patients with CKD are unique and grouped as uremic vascular diseases. One of them, calciphylaxis, typically…
Continue Reading
-
FRESH bioprinting brings vascularized tissue one step closer
Collagen is well-known as an important component of our skin, but its impact is much greater, as it is the most abundant protein in the body, providing structure and support to nearly all tissues and organs. Using their novel Freeform Reversible…
Continue Reading